Stem cell injections deliver concentrated doses of cells into damaged tissue, where they release chemical signals that help the body repair itself. Rather than simply replacing worn-out cells, injected stem cells work primarily by communicating with surrounding tissue, reducing inflammation, and stimulating the body’s own healing processes. These injections are used most commonly for joint pain, particularly knee osteoarthritis, though they’re also marketed for back injuries, shoulder tears, and a range of other conditions.
How Stem Cell Injections Actually Work
The original theory behind stem cell therapy was straightforward: inject new cells, and they’ll grow into whatever tissue is damaged. The reality turns out to be more complex and, in some ways, more interesting. Over the past decade, research has shown that stem cells do most of their work not by transforming into new tissue, but by releasing biological molecules that influence nearby cells. Scientists call this paracrine signaling.
When stem cells are injected into damaged tissue, they release growth factors that trigger several repair processes at once. They stimulate new blood vessel formation, which improves blood supply to the injured area. They calm inflammation by dialing down the immune chemicals that cause swelling and pain. They encourage resident stem cells already living in the tissue to activate and begin repairs. They also release tiny packages called extracellular vesicles, which carry proteins and genetic instructions from cell to cell, essentially reprogramming nearby tissue toward healing rather than scarring.
This signaling creates a gradient around the injection site: cells closest to the stem cells get the strongest signal, while more distant cells receive a weaker one. The result is a localized healing environment that can persist for weeks or months after the injection itself.
Where Stem Cells Come From
Most stem cell injections use mesenchymal stem cells, a type found in several tissues throughout the body. The two most common sources are bone marrow and fat tissue. Less commonly, cells are harvested from umbilical cord blood or tissue donated after birth.
Fat tissue is generally easier and less invasive to collect. A small liposuction procedure under local anesthesia can yield roughly 1 million stem cells, compared to about 24,000 from a typical bone marrow draw. Bone marrow aspiration, on the other hand, involves inserting a hollow needle into the back of the hipbone while you lie on your side or stomach. You’ll receive local anesthesia and possibly a sedative, and you’ll need someone to drive you home afterward.
Age matters for both sources. Stem cells from older donors proliferate more slowly and have reduced ability to develop into cartilage or bone compared to those from younger donors. This is one reason some clinics prefer using donor cells from younger, screened sources rather than harvesting from the patient.
Autologous vs. Donor Cells
Autologous injections use your own cells, harvested and processed during the same visit or shortly before. The advantage is zero risk of immune rejection, since your body recognizes its own cells. The disadvantage is that if you’re older or have a chronic disease, your cells may be less potent.
Allogeneic (donor) injections use cells from a younger, healthy donor. These can be prepared in advance and stored as an off-the-shelf product, making the procedure faster and more standardized. The theoretical risk is immune rejection, but in practice this risk is minimal because mesenchymal stem cells carry very low levels of the surface markers that typically trigger an immune response. Multiple studies have confirmed that donor stem cells are generally well tolerated.
What the Evidence Shows for Knee Osteoarthritis
Knee osteoarthritis is the condition with the most clinical trial data behind stem cell injections. A Cochrane review, widely considered the gold standard for evaluating medical evidence, pooled results from seven randomized controlled trials involving over 400 participants. Compared to placebo injections, stem cell injections improved pain by an average of 1.2 points on a 10-point scale at six months. People who received stem cells rated their pain at 3.3 out of 10, versus 4.5 for placebo. Function scores improved by about 14 points on a 100-point scale.
Those numbers represent a real but modest improvement. The Cochrane reviewers rated the evidence as low certainty, partly because the stem cell preparations varied widely across studies (different sources, doses, and processing methods), and partly because several larger trials were started but never published their results, raising concerns about selective reporting. In practical terms, stem cell injections for knees appear to help, but how much they help and for whom remains unclear.
Recovery and Timeline for Results
The procedure itself is relatively quick. After the injection, most people are advised to modify their activity for two to six weeks before returning to normal routines. That’s considerably shorter than the three to six months of recovery typical after a joint replacement surgery.
Results aren’t immediate. The signaling and repair processes take time to unfold. Many patients begin noticing improvement around three months, though this varies depending on the condition being treated, the severity of the damage, and the type of cells used. For a rotator cuff injury, for example, clinical improvement has been documented at the three-month mark in case studies.
Risks and Side Effects
For outpatient stem cell injections into joints or soft tissue, the most common side effects are mild: temporary pain, swelling, or stiffness at the injection site. Infection is possible any time a needle breaks the skin, though rates are low with proper sterile technique.
The risk profile changes dramatically for stem cell transplants used in cancer treatment, which involve wiping out the patient’s immune system before infusing new cells. These carry serious risks including graft-versus-host disease (where donor cells attack the recipient’s body), organ damage, severe infection, and secondary cancers. These are fundamentally different procedures from the outpatient injections most people are searching about, but the distinction matters because the term “stem cell therapy” covers both.
What’s FDA-Approved and What Isn’t
This is where the landscape gets confusing. The FDA has approved a number of cellular and gene therapy products, but most are for serious conditions like certain blood cancers, genetic diseases, and severe burns. Cord blood products are approved for transplant use. One approved product, MACI, uses a patient’s own cartilage cells cultured on a membrane to repair knee cartilage defects, but it’s a surgical implant rather than a simple injection.
The stem cell injections marketed at orthopedic clinics and regenerative medicine centers for joint pain, back pain, and sports injuries are generally not FDA-approved for those uses. The FDA has taken enforcement action against clinics making unsupported claims, but hundreds of clinics continue to offer these treatments. This doesn’t necessarily mean the treatments don’t work, but it does mean they haven’t undergone the rigorous approval process that would confirm their safety and effectiveness for those specific conditions.
Cost and Insurance Coverage
A single stem cell injection for a knee typically costs between $5,000 and $10,000. For back pain or shoulder injuries, the range extends to $5,000 to $15,000. Insurance generally does not cover these procedures. Medicare covers established bone marrow transplants for conditions like blood cancers, but will not reimburse for the kind of unproven stem cell injections offered at regenerative medicine clinics. This out-of-pocket reality means many patients face significant financial decisions, and some clinics offer payment plans or financing to bridge the gap.